© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
January 19, 2021
A phase 2 study suggests treating the common diabetes comorbidity may be capable with the monoclonal antibody.
January 14, 2021
The SOLOIST-WHF trial indicates that SGLT2 inhibition may lead to an overall reduction in cardiovascular-related deaths and hospitalizations.
A new study finds benefit to hemoglobin A1c reductions made following conception.
January 12, 2021
The study finds that individuals with mothers who had pregestational diabetes had a 2.3-fold increased risk of MS compared to those with non-diabetic mothers.
January 08, 2021
If approved, the treatment would be the first SGLT2 inhibitor for patients with chronic kidney disease.
December 29, 2020
The first approved generic product for injection glucagon is also indicated for diagnostic use, when appropriate.
December 14, 2020
Amputations have increased 30% among diabetic patients since the pandemic began.
December 11, 2020
Despite the increasing push for using HCV-positive organs to expand the donor pool, hundreds of livers allografts from donors are still not being used in transplantation.
December 10, 2020
There is concern over whether or not patients are adhering to their treatment during the pandemic.